| 1 | [SID14745082] | Active | EC50 | 0.059 | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response [AID1045, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.059 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response | | AID | 1045 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID14745082] | Active | EC50 | 0.059 | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response [AID1047, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.059 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response | | AID | 1047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID14745082] | Active | IC50 | 0.064 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | IC50 | 0.064 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 4 | [SID14745082] | Active | IC50 | 0.064 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | IC50 | 0.064 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 5 | [SID14745082] | Active | IC50 | 0.064 | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA [AID856, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | IC50 | 0.064 [uM] | | BioAssay | Counterscreen for S1P2 Antagonists: Dose Response Cell-Based Screen to Identify Antagonists of CRE-BLA | | AID | 856 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 6 | [SID14745082] | Active | Potency | 0.092 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.092 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID14745082] | Active | Potency | 0.092 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.092 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID14745082] | Active | Potency | 0.092 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.092 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID14745082] | Active | Potency | 0.1259 | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1463, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.1259 [uM] | | BioAssay | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1463 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID14745082] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID14745082] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID14745082] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID14745082] | Active | Potency | 0.1472 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.1472 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID14745082] | Active | IC50 | 0.16 | XBP1 DR counterscreen for CHOP [AID504313, Type: confirmatory] | XBP1 [Homo sapiens] [gi:47678753] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | IC50 | 0.16 [uM] | | BioAssay | XBP1 DR counterscreen for CHOP | | AID | 504313 | | BioAssay type | confirmatory | | Target | XBP1 [Homo sapiens] [gi:47678753] | | PubMed | | | Data Table |  |
|
| 15 | [SID14745082] | Active | AC50 | 0.195 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | AC50 | 0.195 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID14745082] | Active | EC50 | 0.249 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to Non-Viral Oncogenic DRD Fibroblast [AID2633, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.249 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to Non-Viral Oncogenic DRD Fibroblast | | AID | 2633 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID14745082] | Active | EC50 | 0.273 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast [AID2631, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.273 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast | | AID | 2631 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID14745082] | Active | EC50 | 0.287 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT Fibroblast [AID2635, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.287 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT Fibroblast | | AID | 2635 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID14745082] | Active | EC50 | 0.438 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJeLR Fibroblast [AID2610, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.438 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJeLR Fibroblast | | AID | 2610 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID14745082] | Active | Potency | 0.5623 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID14745082] | Active | Potency | 0.5623 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 22 | [SID14745082] | Active | Potency | 0.5623 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.5623 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 23 | [SID14745082] | Active | IC50 | 0.587 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | IC50 | 0.587 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 24 | [SID14745082] | Active | IC50 | 0.587 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | IC50 | 0.587 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 25 | [SID14745082] | Active | IC50 | 0.587 | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor [AID851, Type: confirmatory] | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | IC50 | 0.587 [uM] | | BioAssay | Dose Response Cell Based Assay for Antagonists of the S1P2 Receptor | | AID | 851 | | BioAssay type | confirmatory | | Target | sphingosine 1-phosphate receptor 2 [Homo sapiens] [gi:134244587] | | PubMed | | | Data Table |  |
|
| 26 | [SID14745082] | Active | Potency | 0.6513 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 27 | [SID14745082] | Active | Potency | 0.6513 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 28 | [SID14745082] | Active | Potency | 0.6513 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 29 | [SID14745082] | Active | Potency | 0.6513 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 30 | [SID14745082] | Active | Potency | 0.6513 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 31 | [SID14745082] | Active | Potency | 0.6513 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 32 | [SID14745082] | Active | Potency | 0.6513 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 33 | [SID14745082] | Active | EC50 | 0.664 | Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast [AID1936, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.664 [uM] | | BioAssay | Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast | | AID | 1936 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID14745082] | Active | Potency | 0.7079 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 35 | [SID14745082] | Active | Potency | 0.7943 | qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID540256, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 0.7943 [uM] | | BioAssay | qHTS for Inhibitors of binding or entry into cells for Lassa Virus | | AID | 540256 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID14745082] | Active | EC50 | 0.903 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast [AID1934, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 0.903 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to DRD Non-Viral Oncogenic Fibroblast | | AID | 1934 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID14745082] | Active | Potency | 1.4125 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 38 | [SID14745082] | Active | Potency | 1.5849 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 39 | [SID14745082] | Active | Potency | 1.5849 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 40 | [SID14745082] | Active | Potency | 1.9953 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 41 | [SID14745082] | Active | Potency | 1.9953 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 42 | [SID14745082] | Active | Potency | 1.9953 | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 43 | [SID14745082] | Active | EC50 | 2.006 | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT-LT-ST RAS-Independent Fibroblast [AID1935, Type: confirmatory] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | EC50 | 2.006 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT-LT-ST RAS-Independent Fibroblast | | AID | 1935 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID14745082] | Active | Potency | 2.3109 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 2.3109 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 45 | [SID14745082] | Active | Potency | 2.5929 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID14745082] | Active | Potency | 2.8184 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 47 | [SID14745082] | Active | Potency | 2.8184 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 48 | [SID14745082] | Active | Potency | 2.8184 | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 49 | [SID14745082] | Active | Potency | 2.8184 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 50 | [SID14745082] | Active | Potency | 5.1735 | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 14745082 | | CID | 9551964 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|